Credit Suisse Ag Syros Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.69 - $1.21 $21 - $37	31 New	31 $0
Q1 2021 May 14, 2021	SELL	$7.19 - $14.95 $72,302 - $150,337	-10,056 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$6.66 - $14.66 $101,105 - $222,553	-15,181 Reduced 60.15%	10,056 $109,000
Q3 2020 Nov 13, 2020	BUY	$8.69 - $14.47 $219,309 - $365,179	25,237 New	25,237 $223,000
Q4 2017 Feb 14, 2018	SELL	$8.45 - $17.48 $88,826 - $183,749	-10,512 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.52 - $23.75 $142,122 - $249,660	10,512	10,512 $154,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.